Skip to main content
Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data

Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries

Publication ,  Chapter
Otero, CE; Langel, SN; Blasi, M; Permar, SR
January 1, 2021

Duke Scholars

Publication Date

January 1, 2021

Start / End Page

217 / 228
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Otero, C. E., Langel, S. N., Blasi, M., & Permar, S. R. (2021). Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries. In Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data (pp. 217–228).
Otero, C. E., S. N. Langel, M. Blasi, and S. R. Permar. “Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries.” In Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data, 217–28, 2021.
Otero CE, Langel SN, Blasi M, Permar SR. Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries. In: Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data. 2021. p. 217–28.
Otero, C. E., et al. “Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries.” Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data, 2021, pp. 217–28.
Otero CE, Langel SN, Blasi M, Permar SR. Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries. Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data. 2021. p. 217–228.

Publication Date

January 1, 2021

Start / End Page

217 / 228